Next Article in Journal
Shoulder and Neck Pain in Swimmers: Front Crawl Stroke Analysis, Correlation with the Symptomatology in 61 Masters Athletes and Short Literature Review
Previous Article in Journal
Effectiveness of mHealth Interventions for Monitoring Antenatal Care among Pregnant Women in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis
Previous Article in Special Issue
Self at Risk: Self-Esteem and Quality of Life in Cancer Patients Undergoing Surgical Treatment and Experiencing Bodily Deformities
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Anxiety and Depression and Health-Related Quality of Life in Adults with Gastroesophageal Reflux Disease: A Population-Based Study

by
Monira Alwhaibi
1,2
1
Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh 11437, Saudi Arabia
2
Medication Safety Research Chair, College of Pharmacy, King Saud University, Riyadh 11437, Saudi Arabia
Healthcare 2023, 11(19), 2637; https://doi.org/10.3390/healthcare11192637
Submission received: 14 August 2023 / Revised: 10 September 2023 / Accepted: 26 September 2023 / Published: 27 September 2023

Abstract

:
Background: Adults with gastroesophageal reflux disease (GERD) are susceptible to mental disorders that might significantly affect their health-related quality of life (HRQoL). Therefore, the purpose of this study was to evaluate how HRQoL in individuals with GERD is related to coexisting anxiety and depression. Methods: A cross sectional study was conducted among 3068 adult patients 22 years of age and older with GERD diagnoses have been identified using the data from the Medical Expenditure Panel Survey from 2017 to 2020 for United States adults. Data are gathered by MEPS using an overlapping panel design over a period of two and a half years. HRQoL was established using the Physical and Mental Component Summary (PCS & MCS) values from the SF-12. Multivariate forward linear regression analysis was used to assess the relationship between anxiety, depression, and HRQoL in people with GERD after accounting for various factors. Results: Of the 3068 people with GERD who had been identified, 56.4% were women, 59.4% were in their 50s or 60s and 64.8% were employed. Thirteen per cent of people with GERD had depression, thirteen per cent had anxiety, and ten per cent had both. Adults with concurrent anxiety and depression had the lowest mean PCS and MCS scores compared to those with GERD. After adjusting for all independent factors, GERD patients with anxiety (MCS = −10.819, p-value < 0.0001), depression (MCS = −6.395, p-value < 0.0001), and both (MCS= −42.869, p-value < 0.0001) had substantially worse HRQoL than those without these comorbidities. Notably, better HRQoL scores were positively associated with marital status, employment, perceived overall health, and physical activity. Conclusions: The results from this nationally representative sample shed insight into the relationships between low HRQoL and anxiety and depression among individuals with GERD. It also demonstrated the detrimental impacts of co-occurring chronic illnesses, low socioeconomic status, and the positive benefits of employment and exercise on HRQoL. This study emphasizes the clinical, policy, and public health implications for better healthcare, allocation of resources, and promotion of lifestyle modifications to improve the HRQoL in patients with GERD.

1. Introduction

Gastroesophageal reflux disease (GERD) is a chronic, often recurring, persistent condition affecting the digestive system’s upper tract. GERD refers to a condition that develops when the reflux of stomach contents causes troublesome symptoms or complications [1]. Heartburn, chest discomfort, and regurgitation are some examples of typical GERD symptoms [2,3]. GERD is one of the most common medical conditions globally and has been recognized as a significant healthcare issue [4]. According to recent estimates, 13% of people worldwide have GERD, and its incidence is increasing [4]. The estimated worldwide burden of GERD in 2019 was 6.0 million years lived with disability (YLDs), 783 million prevalent cases, and 309 million incident cases [5].
GERD has been associated with various illnesses, such as cancer, psychological and cardiovascular problems [6,7,8]. It harms health, lowers productivity and everyday activities, and impairs health-related quality of life (HRQoL) [6,9,10,11,12]. GERD sufferers are more predisposed to experience significant anxiety and depression. According to a nationwide population-based cohort study of adults, those with GERD had a threefold increased risk of depression and anxiety disorder [7]. Comorbidity of depression or anxiety may impair GERD sufferers’ Health-related quality of life (HRQOL) and increase illness burden [13,14,15]. A post hoc examination of a prospective cohort of 98 patients with GERD at a tertiary referral hospital in Spain revealed an independent relationship between the SF-36 mental component and state anxiety and depression [15]. A study in China among 279 patients with GERD examined the psychological aspects of gastroesophageal reflux disease (GERD) and how they affected patients’ health-related quality of life (HRQOL). It found that all dimensions of SF-36 that measure HRQoL were negatively correlated with anxiety and depression [14]. Anxiety and depression exhibited considerable negative associations with both the physical and mental health of HRQoL in GERD patients, according to another cross-sectional research of 358 GERD patients in Wuhan, China [16]. In a prospective study of 147 GERD patients in the Netherlands, Kessing et al. found that anxiety and depression levels were linked to lower scores for the mental component of HRQoL [17].
For GERD patients, health-related quality of life is a critical outcome determinant that refers to a person’s functions and their perceived physical, mental, and social well-being [18]. One of the key objectives for individuals with GERD is to keep a positive HRQoL despite the difficulties that come with their condition. Therefore, identifying the reasons for a lower HRQoL is essential, particularly in light of the comorbidities related to mental health. There are currently no population-based published data in the US that evaluate the psychological comorbidities of GERD among adults. Additionally, little research assesses the psychological comorbidities’ effects on GERD’s health-related quality of life globally. Previous studies utilized self-reported measures to evaluate anxiety and depression [15,16,17], whereas this study used clinical diagnosis codes. As a result, we investigated GERD in a representative adult population sample. We sought to ascertain the prevalence of psychological disorders among adults with GERD and the influence of psychological comorbidities on GERD health-related quality of life after adjusting for a wide variety of confounders, such as socioeconomic factors, access to treatment, physical activity, and medical comorbidities.

2. Materials and Methods

2.1. Study Design and Data

A cross-sectional study was conducted using data from the Medical Expenditure Panel Survey (MEPS) for 2017, 2018, 2019, and 2020. MEPS is a national survey that gathers information on sociodemographic characteristics, health insurance, medical issues, medication usage, and other health services from the non-institutionalized US civilian population. Data are gathered by MEPS using an overlapping panel design over a period of two and a half years, starting with a preliminary contact and continuing with five rounds of interviews.

2.2. Study Population

The study inclusion criteria are as follows: (1) adults between the ages of 22 and 64; (2) had been diagnosed with gastroesophageal reflux disease (GERD); (3) were alive during the above-mentioned calendar years; (4) and had no missing HRQoL data. Individuals with a GERD diagnosis were identified from the MEPS medical conditions file using the clinical diagnostic codes from the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM).

2.3. Measures

2.3.1. Outcome: Health-Related Quality of Life (HRQoL)

To determine their HRQoL, adults who participated in the MEPS and were at least 18 years old had to self-administer questionnaires. Using the Physical Component Summary (PCS) and Mental Component Summary (MCS) of the Short-Form 12 Version 2 (SF-12V2) questionnaire, the physical and mental components of HRQoL were assessed [19]. Better physical and mental HRQoL is indicated by higher PCS and MCS scores, respectively. The MEPS’s Mental Component Summary Scores (MCS) and Physical Component Summary Scores (PCS) were both found to have high internal consistency reliability, adequate reliability, and validity, and should be appropriate for use in a variety of database-based projects in groups with and without cognitive limitations [19].

2.3.2. Independent Variables

Adults with GERD were divided into four groups (GERD alone, GERD and anxiety, GERD and depression, and GERD and both disorders), each of which were mutually exclusive.
Sociodemographic parameters such as gender, age in years, race or ethnicity, marital status, income, area of residence, education level, health insurance, prescription insurance, job status, and poverty status, were included as independent variables. Poverty status was classified in four groups based on family income with respect to the federal poverty line (FPL): poor, near poor, middle-income, and high-income. Other factors were exercise, concomitant chronic conditions, and subjective physical health.
Using clinical classification codes and ICD-9 cm codes, concurrent chronic illnesses have been identified in the MEPS file. Following verification by expert coders, MEPS researchers converted diseases from household descriptions into clinical classification codes. Expert coders, for instance, used the ICD-9 cm codes 296, 300, and 311 for depression to report individuals with depression in the MEPS file.

2.4. Statistical Analyses

The study population was described using descriptive statistics. The characteristics of the GERD groups were compared using chi-square tests. Using ANOVA, meant that differences in HRQoL between GERD groups were identified. Multivariable forward linear regression model took into account all independent variables (such as sociodemographic factors, physical activity, health insurance coverage, and concurrent chronic health conditions) to assess the relationship between GERD groups and HRQoL. A p-value lower than 0.05 was deemed statistically significant. To account for all estimations, person-level weights and variance adjustment weights (strata and primary sample unit) from the MEPS were used in the statistical analyses. SAS 9.4 was used to analyze the data (SAS Institute Inc., Cary, NC, USA).

3. Results

3.1. Study Sample Characteristics

Table 1 displays the characteristics of the study sample; 3068 individuals with GERD were included in this study. Women (56.4%), adults in their 50s or 60s (59.4%), and those who were employed (64.8%) made up the majority of the sample of adults with GERD. Thirteen per cent of people with GERD had depression, thirteen per cent had anxiety, and ten per cent had both conditions.
Women with GERD experienced considerably higher rates of depression (15.9% vs. 9.9%) and anxiety (12.9% vs. 7.4%, p-value < 0.0001) than males did. Additionally, GERD patients who were unemployed had significantly higher rates of depression (17.7% vs. 10.9%) and comorbid anxiety and depression (15.4% vs. 7.8%, p-value < 0.0001) than those who were in employment. Additionally, patients with GERD who had these comorbidities (hypertension, diabetes, asthma, Chronic Obstructive Pulmonary Disease (COPD), arthritis, and osteoporosis) had a considerably higher percentage of depression and anxiety than adults with GERD without these comorbidities (p-value < 0.0001).

3.2. Mean Health-Related Quality of Life Scores by GERD Groups

There were significant differences between the GERD groups in the PCS and MCS scores for HRQoL (Table 2). For instance, the mean PCS score was lower in GERD patients who also had depression and anxiety (Mean = 33.41) than it was in the other groups (GERD only, GERD and depression, and GERD and anxiety, which had mean PCS scores of 43.90, 38.67, and 39.86, respectively). Similarly, the MCS score was lower in GERD patients who also had depression and/or anxiety compared to other groups (35.61 for GERD and depression and/or anxiety, 39.90 for GERD only, and 38.12 for GERD & anxiety).

3.3. Multivariate Adjusted Analysis of Factors Associated with HRQoL in Patients with GERD

Table 3 shows how GERD groups and HRQoL are related after adjustment. After controlling for all independent variables, GERD patients with depression (MCS: = −6.395, p-value = 0.0001), anxiety (MCS: = −2.869, p-value = 0.0001), and both (MCS: = −10.819, p-value = 0.0001) had significantly poorer HRQoL than those without these comorbidities.
Factors negatively associated with HRQoL include young age, female gender, poverty status, health insurance, and comorbidities, including heart disease, hypertension, diabetes, hyperlipidemia, asthma, COPD, arthritis, and cancer. For instance, when compared to people with high income, poor adults had lower HRQoL for both their physical health summary score (PCS: = −2.230, p-value < 0.0001) and their mental health summary score (MCS: = −0.363, p-value < 0.0001).
Factors positively associated with HRQoL included marital status, employment, perceived general health, and physical activity. For instance, persons who were employed had greater HRQoL than those who were unemployed in terms of both the physical health summary score (PCS: = 5.909, p-value < 0.0001) and the mental health summary score (MCS: = 2.819, p-value < 0.0001).

4. Discussion

This research provides insight into the relationship between GERD sufferers’ physical and mental comorbidities and HRQoL. According to our study, patients with GERD and comorbidities of depression and anxiety had considerably lower health-related quality of life (HRQoL) than those without these comorbidities.
According to earlier published studies, in individuals with GERD, mental comorbidities have a negative impact on HRQoL. For example, studies in Spain [15], China [14,16], and the Netherlands [17], reported that all dimensions of SF-36 that measure HRQoL were negatively correlated with anxiety and depression in GERD patients. According to recent a systematic review and meta-analysis, GERD patients’ levels of anxiety and depression were higher than those of healthy controls [20]. Based on the pooled results of 30 studies, the prevalences of anxiety and depressive symptoms were 34.4% and 24.2% in GERD patients, respectively [20]. Additionally, a positive correlation between heartburn symptoms and psychological disorders was discovered [21].
Factors negatively associated with HRQoL in this study included young age, female gender, poverty status, health insurance, and concurrent comorbidities. With regard to gender and income, our finding is consistent with previous studies that reported an association between the female gender and lower physical component of the SF36 [15] and low income and poor HRQoL [22]. Maintaining people’s health is heavily influenced by income, a fundamental measure of social class. Higher income is associated with improved health and reduced health risks, whereas lower income is associated with greater exposure to risk factors for developing diseases [22]. In terms of health insurance, our findings shed light on the negative relationship between having health insurance and poor HRQoL, this finding contradicts the findings by Bharmal et al., who used MEPS data for the year 2000 and reported that individuals without health insurance had significantly lower mean PCS scores and MCS scores than those with health insurance [23]. The different study populations might cause this discrepancy, whereas we looked at adults with GERD, Bharmal et al. study looked at adults as a whole.
Regarding comorbidities, our study found that patients with heart disease, hypertension, diabetes, hyperlipidemia, asthma, COPD, arthritis, and cancer were negatively associated with HRQoL. Previous studies have described that individuals with chronic diseases experience lower HRQoL due to the chronic nature of the diseases and their management and that chronic diseases are related to mental health [24,25,26]. HRQoL has been investigated as a primary or secondary outcome in chronic illnesses research [26], as improving HRQoL is considered a significant outcome and a predictor of the therapeutic benefit of disease management. Health services could become more patient-centered with data on the influence of chronic conditions on HRQoL.
Factors positively associated with HRQoL in our study included marital status, employment, perceived general health, and physical activity; these findings are consistent with published studies. For example, employment has been positively associated with HRQoL in patients with multiple sclerosis [27] and liver transplant patients [28]. Physical activity has been reported to be positively associated with HRQoL by many published studies in the general adult population [29,30]. A systematic review of fourteen observational studies revealed a positive relationship between physical activity level and health-related quality of life [29].

4.1. Study Strengths and Limitations

This study used a nationally representative sample of US adult GERD sufferers, with a large sample size to examine how depression and anxiety related to their HRQoL, while previously published studies [14,15,16,17] were conducted in a single center and sample size of these studies ranged from 98 to 358 patients with GERD. We adjusted for several factors in our analysis, such as coexisting chronic conditions, physical activity, health insurance coverage, and sociodemographic characteristics. However, it’s crucial to consider a few limitations when evaluating the study’s results. Since GERD types and illness severity are unavailable in MEPS, they were not accounted for in the regression analysis. Additionally, the MEPS does not provide information relating to the degree of anxiety or depression, which may affect the HRQoL of individuals with GERD; as a result, the regression analysis did not consider this information. Furthermore, due to the cross-sectional nature of this study, establishing the causal relationship is challenging. Finally, the results cannot be extrapolated to older people because MEPS only provides information for adults.

4.2. Clinical and Practice Implications

The information reported in this study may be used by healthcare professionals and policymakers to improve healthcare planning and resource allocation to reduce the adverse consequences of anxiety and depression on individuals with GERD. Additionally, this study recommends that healthcare practitioners should regularly test for anxiety and depression and treat these conditions since early diagnosis and treatment can enhance HRQoL in individuals with GERD. This study has significance in public health as it promotes lifestyle modifications, such as exercise, which can greatly reduce the frequency and severity of mental health issues and GERD problems.
Gastroesophageal reflux disease (GERD) continues to be one of the most prevalent ailments that healthcare providers continue to treat. While proton pump inhibitors (PPIs) remain the preferred medical treatment for GERD, numerous publications have questioned their side effects, questioned the safety of long-term usage, and raised concerns about overprescribing PPIs [31]. The potential for treating GERD using pharmaceutical, dietary, surgical, and endoscopic methods is now better understood.

5. Conclusions

The results from this nationally representative sample shed insight on the relationships between low HRQoL and anxiety and depression among individuals with GERD. It also demonstrated the detrimental impacts of co-occurring chronic illnesses, low socioeconomic status, and the positive benefits of employment and exercise on HRQoL. This study emphasizes the clinical, political, and public health implications for better healthcare, allocation of resources, and promotion of lifestyle modifications to improve the HRQoL in patients with GERD.

Funding

The author extend her appreciation to the Deputyship for Research & Innovation, “Ministry of Education” in Saudi Arabia for funding this research work through the project no. (IFKSUOR3-166-3).

Institutional Review Board Statement

This study did not require ethical review or approval because it utilized a publicly accessible secondary database, the Medical Expenditure Panel Survey (MEPS) database.

Informed Consent Statement

Due to the fact that this study employed a secondary database, the Medical Expenditure Panel Survey (MEPS) database, which is publicly accessible, patient consent was waived for this research.

Data Availability Statement

Researchers can access the publicly accessible dataset used in this study from the MEPS database at this URL: https://meps.ahrq.gov/data_stats/download_data_files.jsp (accessed on 8 June 2023).

Conflicts of Interest

The author declares that there is no conflict of interest regarding the publication of this paper.

Abbreviations

HRQoL: Health-Related Quality of Life, MCS: mental health component score, PCS: physical health component score.

References

  1. Vakil, N.; van Zanten, S.V.; Kahrilas, P.; Dent, J.; Jones, R.; Global Consensus, G. The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus. Off. J. Am. Coll. Gastroenterol. ACG 2006, 101, 1900–1920. [Google Scholar] [CrossRef] [PubMed]
  2. Moayyedi, P.; Talley, N.J. Gastro-oesophageal reflux disease. Lancet 2006, 367, 2086–2100. [Google Scholar] [CrossRef] [PubMed]
  3. Fass, R.; Boeckxstaens, G.E.; El-Serag, H.; Rosen, R.; Sifrim, D.; Vaezi, M.F. Gastro-oesophageal reflux disease. Nat. Rev. Dis. Primers 2021, 7, 021–00287. [Google Scholar] [CrossRef] [PubMed]
  4. Eusebi, L.H.; Ratnakumaran, R.; Yuan, Y.; Solaymani-Dodaran, M.; Bazzoli, F.; Ford, A.C. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: A meta-analysis. Gut 2018, 67, 430–440. [Google Scholar] [CrossRef]
  5. Li, N.; Yang, W.L.; Cai, M.H.; Chen, X.; Zhao, R.; Li, M.T.; Yan, X.L.; Xue, L.W.; Hong, L.; Tang, M.Y. Burden of gastroesophageal reflux disease in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of disease study 2019. BMC Public Health 2023, 23, 582. [Google Scholar] [CrossRef]
  6. Maret-Ouda, J.; Markar, S.R.; Lagergren, J. Gastroesophageal Reflux Disease: A Review. Jama 2020, 324, 2536–2547. [Google Scholar] [CrossRef]
  7. You, Z.H.; Perng, C.L.; Hu, L.Y.; Lu, T.; Chen, P.M.; Yang, A.C.; Tsai, S.J.; Huang, Y.S.; Chen, H.J. Risk of psychiatric disorders following gastroesophageal reflux disease: A nationwide population-based cohort study. Eur. J. Int. Med. 2015, 26, 534–539. [Google Scholar] [CrossRef]
  8. Chen, C.H.; Lin, C.L.; Kao, C.H. Association between gastroesophageal reflux disease and coronary heart disease: A nationwide population-based analysis. Medicine 2016, 95, 0000000000004089. [Google Scholar] [CrossRef]
  9. Min, Y.W.; Shin, Y.W.; Cheon, G.J.; Park, K.S.; Kim, H.S.; Sohn, C.-I.; Kim, T.N.; Moon, H.C.; Rhee, P.-L. Recurrence and Its Impact on the Health-related Quality of Life in Patients with Gastroesophageal Reflux Disease: A Prospective Follow-up Analysis. J. Neurogastroenterol. Motil. 2016, 22, 86–93. [Google Scholar] [CrossRef]
  10. Fuchs, K.-H.; Musial, F.; Eypasch, E.; Meining, A. Gastrointestinal Quality of Life in Gastroesophageal Reflux Disease: A Systematic Review. Digestion 2022, 103, 253–260. [Google Scholar] [CrossRef]
  11. Gralnek, I.M. Diagnosis and management of gastroesophageal reflux disease in the primary care setting: Can health-related quality of life play a role? Am. J. Gastroenterol. 2001, 96, S54–S56. [Google Scholar] [CrossRef] [PubMed]
  12. Wahlqvist, P. Symptoms of gastroesophageal reflux disease, perceived productivity, and health-related quality of life. Am. J. Gastroenterol. 2001, 96, S57–S61. [Google Scholar] [CrossRef] [PubMed]
  13. Chen, G.; Xie, J.; Ye, J.; Kuang, X.; Liao, W.; Song, L.; Zhang, X. Depression Promotes Gastroesophageal Reflux Disease: New Evidence Based on Mendelian Randomization. Turk. J. Gastroenterol. Off. J. Turk. Soc. Gastroenterol. 2023, 34, 457–462. [Google Scholar] [CrossRef] [PubMed]
  14. Yang, X.-J.; Jiang, H.-M.; Hou, X.-H.; Song, J. Anxiety and depression in patients with gastroesophageal reflux disease and their effect on quality of life. World J. Gastroenterol. 2015, 21, 4302–4309. [Google Scholar] [CrossRef]
  15. Zatarain Valles, A.; Serrano Falcón, B.; Álvarez Sánchez, Á.; Rey Díaz-Rubio, E. Independent factors associated with the impact of gastroesophageal reflux disease on health-related quality of life. Rev. Esp. De Enfermedades Dig. Organo Of. De La Soc. Esp. De Patol. Dig. 2019, 111, 94–100. [Google Scholar] [CrossRef]
  16. Zhang, L.; Tu, L.; Chen, J.; Song, J.; Bai, T.; Xiang, X.-L.; Wang, R.-Y.; Hou, X.-H. Health-related quality of life in gastroesophageal reflux patients with noncardiac chest pain: Emphasis on the role of psychological distress. World J. Gastroenterol. 2017, 23, 127–134. [Google Scholar] [CrossRef]
  17. Kessing, B.F.; Bredenoord, A.J.; Saleh, C.M.G.; Smout, A.J.P.M. Effects of anxiety and depression in patients with gastroesophageal reflux disease. Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc. 2015, 13, 1089. [Google Scholar] [CrossRef]
  18. Karimi, M.; Brazier, J. Health, Health-Related Quality of Life, and Quality of Life: What is the Difference? PharmacoEconomics 2016, 34, 645–649. [Google Scholar] [CrossRef]
  19. Cheak-Zamora, N.C.; Wyrwich, K.W.; McBride, T.D. Reliability and validity of the SF-12v2 in the medical expenditure panel survey. Qual. Life Res. 2009, 18, 727–735. [Google Scholar] [CrossRef]
  20. Zamani, M.; Alizadeh-Tabari, S.; Chan, W.W.; Talley, N.J. Association Between Anxiety/Depression and Gastroesophageal Reflux: A Systematic Review and Meta-Analysis. Am. J. Gastroenterol. 2023, 21, 0000000000002411. [Google Scholar] [CrossRef]
  21. Haug, T.T.; Mykletun, A.; Dahl, A.A. Are anxiety and depression related to gastrointestinal symptoms in the general population? Scand. J. Gastroenterol. 2002, 37, 294–298. [Google Scholar] [CrossRef] [PubMed]
  22. Zhang, S.; Xiang, W. Income gradient in health-related quality of life—The role of social networking time. Int. J. Equity Health 2019, 18, 44. [Google Scholar] [CrossRef] [PubMed]
  23. Bharmal, M.; Thomas, J. Health insurance coverage and health-related quality of life: Analysis of 2000 Medical Expenditure Panel Survey data. J. Health Care Poor Underserved 2005, 16, 643–654. [Google Scholar] [CrossRef] [PubMed]
  24. Park, Y.; Park, K. Health-related quality of life and depressive symptoms of patients with chronic diseases and the general population before and during the COVID-19 pandemic in Korea. Front Psychol. 2023, 14, 1117369. [Google Scholar] [CrossRef] [PubMed]
  25. Maynié-François, C.; Burtey, S. Comparing health-related quality of life in chronic diseases: The importance of analyzing references. Nat. Rev. Dis. Primers 2019, 5, 28. [Google Scholar] [CrossRef]
  26. Megari, K. Quality of Life in Chronic Disease Patients. Health Psychol. Res. 2013, 1, 24. [Google Scholar] [CrossRef]
  27. Miller, A.; Dishon, S. Health-related Quality of Life in Multiple Sclerosis: The Impact of Disability, Gender and Employment Status. Qual. Life Res. 2006, 15, 259–271. [Google Scholar] [CrossRef]
  28. Åberg, F.; Rissanen, A.M.; Sintonen, H.; Roine, R.P.; Höckerstedt, K.; Isoniemi, H. Health-related quality of life and employment status of liver transplant patients. Liver Transplant. 2009, 15, 64–72. [Google Scholar] [CrossRef]
  29. Bize, R.; Johnson, J.A.; Plotnikoff, R.C. Physical activity level and health-related quality of life in the general adult population: A systematic review. Prev. Med. 2007, 45, 401–415. [Google Scholar] [CrossRef]
  30. Anokye, N.K.; Trueman, P.; Green, C.; Pavey, T.G.; Taylor, R.S. Physical activity and health related quality of life. BMC Public Health 2012, 12, 624. [Google Scholar] [CrossRef]
  31. Katz, P.O.; Dunbar, K.B.; Schnoll-Sussman, F.H.; Greer, K.B.; Yadlapati, R.; Spechler, S.J. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am. J. Gastroenterol. 2022, 117, 27–56. [Google Scholar] [CrossRef] [PubMed]
Table 1. Characteristics of the Study Sample (n = 3068), N and Row % of Characteristics by GERD Group among Adults with GERD, Medical Expenditure Panel Survey 2017–2020.
Table 1. Characteristics of the Study Sample (n = 3068), N and Row % of Characteristics by GERD Group among Adults with GERD, Medical Expenditure Panel Survey 2017–2020.
Total Sample GERD Only GERD & Depression GERD & Anxiety GERD & Dep & Anxiety
N Wt.%N Wt.% N Wt.% N Wt.% N Wt.% p-Value
All3068100.0189863.040513.339413.237110.5
Age in years
  22–3950918.930860.64110.28415.37613.90.036
  40–4964521.737859.49215.38213.49311.9
  50–64191459.4121265.127213.622812.42028.9
Gender
  Women182056.4101256.428415.926314.826112.9<0.0001
  Men124843.688671.51219.913111.11107.4
Race/ethnicity
  White202875.0118960.828114.029614.326210.90.048
  African American50711.634569.36110.6489.75310.3
  Latino3608.224471.9358.4349.24710.5
  others1735.212066.52816.51610.996.1
Marital Status 371
  Married160557.2108867.718011.919613.01417.4<0.0001
  Wid./Div./Sep.87325.147956.214316.812113.313013.8
  Never married59017.733157.68212.87713.810015.8
Education Level
  LT HS1192.67059.62421.41614.394.80.226
  HS3158.218658.73912.54414.34614.5
  >HS261288.6162563.434013.133413.131310.3
Region
  Northeast61420.938765.86510.17011.89212.30.089
  Mid-west74124.542560.111314.810814.29510.8
  South118038.773962.614312.316415.013410.1
  West53315.934764.88417.6528.8508.8
Employment
  Employed180964.8125369.218510.920912.01627.8<0.0001
  Not employed125935.264551.622017.718515.320915.4
Poverty Status
  Poor60313.931953.19717.07511.611218.3<0.0001
  Near Poor51313.528957.27714.16313.38415.4
  Middle Income81026.547960.110412.613316.49411.0
  High Income114246.181169.412712.412311.8816.4
Health Insurance
  Private192971.0130667.623212.422212.21697.8<0.0001
  Public106827.454350.616916.316415.719217.4
  Uninsured711.64968.943.0813.31014.9
Rx Insurance
  Rx insurance173164.6118868.320512.619611.91427.2<0.0001
  No Rx insurance133735.471053.320014.619815.622916.5
General Health
  Excellent/very good97336.371873.08910.210811.8585.0<0.0001
  Good109835.468461.313312.315715.212411.3
  Fair/poor99728.349652.318318.712912.418916.6
Physical activity
  3/week121141.484171.41239.214111.71067.7<0.0001
  No exercise184257.9104757.127815.925314.426412.6
Heart
  Yes38611.021761.36616.2489.95512.60.188
  No268289.0168163.233913.034613.631610.3
Hypertension
  Yes149845.385058.723115.222314.919411.20.009
  No157054.7104866.617411.817111.717710.0
Diabetes
  Yes67018.635353.212918.78513.810314.3<0.0001
  No239881.4154565.227612.130913.02689.6
Hyperlipidemia
  Yes113934.766659.317014.215014.815311.80.137
  No192965.3123265.023512.924412.32189.8
Asthma
  Yes59317.228651.18414.310817.211517.4<0.0001
  No247582.8161265.532113.128612.32569.1
COPD
  Yes3319.615146.55315.45616.57121.6<0.0001
  No273790.4174764.735213.133812.83009.3
Arthritis
  Yes65818.834952.910817.28613.111516.9<0.0001
  No241081.2154965.329712.430813.22569.0
Osteoporosis
  Yes431.51425.81236.21129.468.6<0.0001
  No302598.5188463.639313.038312.936510.5
Cancer
  Yes1394.67554.72018.01710.62716.70.059
  No292995.4182363.438513.137713.334410.2
COPD: Chronic Obstructive Pulmonary Disease; Dep: Depression; GERD: Gastroesophageal reflux disease; Rx: Medication; LT: less than; Wt.: weighted; Wid./Div./Sep.: widowed, divorced, and separated.
Table 2. Health-related Quality of Life Scores by GERD Groups.
Table 2. Health-related Quality of Life Scores by GERD Groups.
Total SampleGERD OnlyGERD & DepressionGERD & AnxietyGERD & Depression & Anxiety
Mean SDMean SEMean SEMean SEMean SEp-Value
HRQoL
PCS37.3919.143.900.6438.671.2739.861.3133.411.30<0.0001
MCS41.0519.339.900.6935.991.2838.121.3135.611.48<0.0001
MCS: Mental Component Summary; PCS: Physical Component Summary; SE: Standard Error; SD: Standard Deviation.
Table 3. Adjusted Multivariate Linear Regressions on Health-related Quality of Life among Adults with GERD, MEPS 2017–2020.
Table 3. Adjusted Multivariate Linear Regressions on Health-related Quality of Life among Adults with GERD, MEPS 2017–2020.
Health-Related Quality of Life
PCS MCS
Regression
Coefficients
p-ValueSig.Regression
Coefficients
p-ValueSig.
GERD Groups
  GERD & depression−0.654<0.0001***−6.395<0.0001***
  GERD & anxiety1.215<0.0001***−2.869<0.0001***
  GERD & depression & anxiety−0.368<0.0001***−10.819<0.0001***
  GERD only (Ref.)
Age in years
  22–392.620<0.0001***−1.636<0.0001***
  40–490.177<0.0001***−0.284<0.0001***
  50–64 (Ref.)
Gender
  Women−0.561<0.0001***−0.200<0.0001***
  Men (Ref.)
Race/ethnicity
  White0.129<0.0001***−1.441<0.0001***
  Afr Am0.898<0.0001***0.034<0.0001***
  Latino1.858<0.0001***1.322<0.0001***
  others (Ref.)
Marital Status
  Married1.544<0.0001***1.826<0.0001***
  Widow/Sep/Div1.055<0.0001***−0.044<0.0001***
  Never married (Ref.)
Education Level
  >HS1.424<0.0001***2.640<0.0001***
  HS1.524<0.0001***3.960<0.0001***
  LT HS (Ref.)
Region
  Northeast1.532<0.0001***1.595<0.0001***
  Mid-west0.320<0.0001***0.854<0.0001***
  South−0.299<0.0001***0.476<0.0001***
  West (Ref.)
Employment
  Employed5.909<0.0001***2.819<0.0001***
  Not employed (Ref.)
Poverty Status
  Poor −2.230<0.0001***−0.363<0.0001***
  Near Poor−1.599<0.0001***0.402<0.0001***
  Middle Income−1.757<0.0001***−0.394<0.0001***
  High Income (Ref.)
Health Insurance
  Private−3.394<0.0001***−0.878<0.0001***
  Public−1.785<0.0001***−2.199<0.0001***
  Uninsured (Ref.)
Rx Insurance
  Rx insurance2.420<0.0001***1.219<0.0001***
  No Rx insurance (Ref.)
General Health
  Excellent/very good10.457<0.0001***5.627<0.0001***
  Good6.218<0.0001***3.958<0.0001***
  Fair/poor (Ref.)
Physical Activity
  3/week1.846<0.0001***0.481<0.0001***
  No exercise (Ref.)
Heart
  Yes−2.853<0.0001***−0.277<0.0001***
Hypertension
  Yes−1.480<0.0001***0.355<0.0001***
Diabetes
  Yes−1.850<0.0001***1.129<0.0001***
Hyperlipidemia
  Yes−0.528<0.0001***−0.761<0.0001***
Asthma
  Yes−1.172<0.0001***0.299<0.0001***
COPD
  Yes−1.357<0.0001***0.485<0.0001***
Arthritis
  Yes−3.572<0.0001***0.225<0.0001***
Osteoporosis
  Yes6.278<0.0001***−1.906<0.0001***
Cancer
  Yes−1.847<0.0001***−2.693<0.0001***
Asterisks denote statistical significance in parameter estimates from multivariate linear regressions on health-related quality of life. *** p <0.001. GERD: Gastroesophageal reflux disease; HS: High School; LT: less than; MCS: Mental Component Summary; PCS: Physical Component Summary; Rx: Medication; Ref: reference group; Sig: Significance. Wid./Div./Sep.: widowed, divorced, and separated.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Alwhaibi, M. Anxiety and Depression and Health-Related Quality of Life in Adults with Gastroesophageal Reflux Disease: A Population-Based Study. Healthcare 2023, 11, 2637. https://doi.org/10.3390/healthcare11192637

AMA Style

Alwhaibi M. Anxiety and Depression and Health-Related Quality of Life in Adults with Gastroesophageal Reflux Disease: A Population-Based Study. Healthcare. 2023; 11(19):2637. https://doi.org/10.3390/healthcare11192637

Chicago/Turabian Style

Alwhaibi, Monira. 2023. "Anxiety and Depression and Health-Related Quality of Life in Adults with Gastroesophageal Reflux Disease: A Population-Based Study" Healthcare 11, no. 19: 2637. https://doi.org/10.3390/healthcare11192637

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop